Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AMETEK, Inc. stock logo
AME
AMETEK
$178.44
+0.9%
$169.22
$145.02
$198.33
$41.20B1.121.29 million shs1.04 million shs
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$1.06
+6.7%
$1.10
$0.92
$2.50
$402.61M1.52.11 million shs1.10 million shs
DeepMarkit Corp. stock logo
MKT
DeepMarkit
C$0.05
-18.2%
C$0.05
C$0.04
C$0.20
C$556K0.2416,103 shs45,000 shs
Prenetics Global Limited stock logo
PRE
Prenetics Global
$8.32
+1.3%
$5.94
$3.09
$11.99
$101.55M0.1719,331 shs19,243 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AMETEK, Inc. stock logo
AME
AMETEK
+0.88%-0.23%+5.05%-3.08%+5.80%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
+7.07%+2.42%+4.43%-8.62%-58.75%
DeepMarkit Corp. stock logo
MKT
DeepMarkit
0.00%0.00%-18.18%-35.71%-74.29%
Prenetics Global Limited stock logo
PRE
Prenetics Global
+1.34%-12.42%+60.03%+71.19%+36.39%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AMETEK, Inc. stock logo
AME
AMETEK
4.1611 of 5 stars
2.33.02.52.02.42.51.9
Standard BioTools Inc. stock logo
LAB
Standard BioTools
2.5653 of 5 stars
3.33.00.00.01.53.30.6
DeepMarkit Corp. stock logo
MKT
DeepMarkit
N/AN/AN/AN/AN/AN/AN/AN/A
Prenetics Global Limited stock logo
PRE
Prenetics Global
1.4211 of 5 stars
1.55.00.00.02.60.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AMETEK, Inc. stock logo
AME
AMETEK
2.64
Moderate Buy$197.8910.90% Upside
Standard BioTools Inc. stock logo
LAB
Standard BioTools
2.50
Moderate Buy$2.50135.85% Upside
DeepMarkit Corp. stock logo
MKT
DeepMarkit
0.00
N/AN/AN/A
Prenetics Global Limited stock logo
PRE
Prenetics Global
3.00
Buy$9.008.17% Upside

Current Analyst Ratings Breakdown

Latest MKT, AME, LAB, and PRE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/16/2025
AMETEK, Inc. stock logo
AME
AMETEK
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$212.00
5/7/2025
AMETEK, Inc. stock logo
AME
AMETEK
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$197.00 ➝ $190.00
5/5/2025
AMETEK, Inc. stock logo
AME
AMETEK
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$196.00 ➝ $200.00
5/2/2025
AMETEK, Inc. stock logo
AME
AMETEK
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$194.00 ➝ $201.00
4/14/2025
AMETEK, Inc. stock logo
AME
AMETEK
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$170.00
4/8/2025
AMETEK, Inc. stock logo
AME
AMETEK
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$216.00 ➝ $196.00
(Data available from 6/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AMETEK, Inc. stock logo
AME
AMETEK
$6.94B5.94$8.16 per share21.88$41.74 per share4.28
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$169.69M2.37N/AN/A($1.85) per share-0.57
DeepMarkit Corp. stock logo
MKT
DeepMarkit
-C$102.00-5,448.53C$0.01 per share5.00C($0.03) per share-1.50
Prenetics Global Limited stock logo
PRE
Prenetics Global
$30.62M3.32N/AN/A$17.22 per share0.48
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AMETEK, Inc. stock logo
AME
AMETEK
$1.38B$6.1130.0923.082.7319.83%16.94%10.73%7/30/2025 (Estimated)
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-$74.66M-$0.35N/AN/AN/A-79.92%-27.05%-15.52%7/30/2025 (Estimated)
DeepMarkit Corp. stock logo
MKT
DeepMarkit
-C$6.31M-C$0.06N/AN/AN/A-295.34%-190.23%N/A
Prenetics Global Limited stock logo
PRE
Prenetics Global
-$62.72M-$3.99N/AN/AN/A-191.73%-16.45%-13.34%6/17/2025 (Estimated)

Latest MKT, AME, LAB, and PRE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025Q1 2025
AMETEK, Inc. stock logo
AME
AMETEK
$1.69$1.75+$0.06$1.52$1.74 billion$1.73 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AMETEK, Inc. stock logo
AME
AMETEK
$1.240.69%N/A20.29%6 Years
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/AN/AN/AN/AN/A
DeepMarkit Corp. stock logo
MKT
DeepMarkit
N/A3.57%N/AN/AN/A
Prenetics Global Limited stock logo
PRE
Prenetics Global
$2.8033.65%N/AN/A N/A

Latest MKT, AME, LAB, and PRE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/8/2025
AMETEK, Inc. stock logo
AME
AMETEK
quarterly$0.310.73%6/13/20256/13/20256/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AMETEK, Inc. stock logo
AME
AMETEK
0.15
1.24
0.75
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/A
3.76
3.41
DeepMarkit Corp. stock logo
MKT
DeepMarkit
0.82
0.35
4.68
Prenetics Global Limited stock logo
PRE
Prenetics Global
N/A
1.40
1.22

Institutional Ownership

CompanyInstitutional Ownership
AMETEK, Inc. stock logo
AME
AMETEK
87.43%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
53.74%
DeepMarkit Corp. stock logo
MKT
DeepMarkit
N/A
Prenetics Global Limited stock logo
PRE
Prenetics Global
25.01%

Insider Ownership

CompanyInsider Ownership
AMETEK, Inc. stock logo
AME
AMETEK
0.57%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
23.16%
DeepMarkit Corp. stock logo
MKT
DeepMarkit
8.42%
Prenetics Global Limited stock logo
PRE
Prenetics Global
7.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
AMETEK, Inc. stock logo
AME
AMETEK
19,600230.88 million229.90 millionOptionable
Standard BioTools Inc. stock logo
LAB
Standard BioTools
620379.82 million174.59 millionOptionable
DeepMarkit Corp. stock logo
MKT
DeepMarkit
6,40012.35 millionN/ANot Optionable
Prenetics Global Limited stock logo
PRE
Prenetics Global
112.21 million11.25 millionNot Optionable

Recent News About These Companies

Prenetics Global Limited (PRENW)
Prenetics Global Ltd trading resumes
Prenetics Global Ltd trading halted, volatility trading pause
Cantor Fitzgerald Sticks to Their Buy Rating for Prenetics Group (PRE)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AMETEK stock logo

AMETEK NYSE:AME

$178.44 +1.51 (+0.85%)
Closing price 06/6/2025 03:59 PM Eastern
Extended Trading
$178.34 -0.10 (-0.06%)
As of 06/6/2025 05:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry. Its EMG segment offers engineered medical components and devices, automation solutions, thermal management systems, specialty metals, and electrical interconnects; single-use and consumable surgical instruments, implantable components, and drug delivery systems; engineered electrical connectors and electronics packaging to protect sensitive devices and mission-critical electronics; precision motion control products for data storage, medical devices, business equipment, and automation; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for thermal management, military and commercial aircraft, and military ground vehicles; motors for commercial appliances, food and beverage machines, hydraulic pumps, and industrial blowers; and operates a network of aviation maintenance, repair, and overhaul facilities. AMETEK, Inc. was incorporated in 1930 and is headquartered in Berwyn, Pennsylvania.

Standard BioTools stock logo

Standard BioTools NASDAQ:LAB

$1.06 +0.07 (+6.65%)
Closing price 06/6/2025 04:00 PM Eastern
Extended Trading
$1.08 +0.01 (+1.42%)
As of 06/6/2025 07:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

DeepMarkit stock logo

DeepMarkit CVE:MKT

C$0.04 -0.01 (-18.18%)
As of 06/3/2025 01:32 PM Eastern

DeepMarkit Corp. provides game-based marketing software services. The company operates DeepMarkit platform and MintCarbon.io platform, a web-based software-as-a-service platform that facilitates the minting of carbon credits into non-fungible tokens. The company was formerly known as Challenger Deep Resources Corp. and changed its name to DeepMarkit Corp. in October 2015. DeepMarkit Corp. was incorporated in 2007 and is headquartered in Calgary, Canada.

Prenetics Global stock logo

Prenetics Global NASDAQ:PRE

$8.32 +0.11 (+1.34%)
Closing price 06/6/2025 03:59 PM Eastern
Extended Trading
$8.26 -0.06 (-0.72%)
As of 06/6/2025 04:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.